Green Dot stock is a "Buy" as revenue jumped 21% to $2.08 billion. Learn how GDOT's split and bank merger could impact its ...

ClearPoint Neuro lost more than 14% on Wednesday after its FY26 revenue guidance fell short of analysts’ estimates. The stock ...

IAMGOLD (IAG) has transformed operationally, delivering record revenue, EBITDA, and cash flow in 2025, and now trades at 6x ...

Quantum eMotion (QNC) looks overvalued vs weak revenues; small grant/partnership don’t justify $550M cap. Click here to read ...

Q3 2026 earnings call highlights: guidance reaffirmed, margin recovery outlook, Brazil divestiture, and innovation drivers.

Tenax Therapeutics is a single-asset biotech advancing oral levosimendan (TNX-103) for PH-HFpEF, with pivotal LEVEL readout expected in Q3. Despite optimistic assumptions—50% POS, 100k Target Pop., 15 ...

JPMorgan Industrials Conference 2026 March 18, 2026 10:05 AM EDTCompany ParticipantsMichael Wagnes - Senior VP & CFOConference ...

John Hancock Multimanager 2035 Lifetime Portfolio posted a gain but slightly underperformed its benchmark. Asset allocation ...

Platinum (XPTUSD:CUR) traded downward today, with the metal giving back recent gains as traders took into consideration the ...

Agnico Eagle Mines stock remains a "Buy" after a strong Q4, a 12.5% dividend hike, and a $2 billion buyback. Learn more about ...

The Janus Henderson AAA CLO ETF focuses on high-quality AAA-rated CLOs. Credit and rate risk are both negligible, default ...

Evolution AB (EVVTY) outlook: slowing growth, saturation, and regulatory risks vs 65%+ EBITDA margins and strong cash flow.